Obesity impairs the adaptive immune response to influenza virus

Annals of the American Thoracic Society

Volumn 14, Issue , 2017, Pages S406-S409

  Green, William D ^a   Beck, Melinda A ^a  

^a University of North Carolina at Chapel Hill   (United States)

Author keywords

Immunity; Influenza; Obesity; Vaccination

Indexed keywords

INFLUENZA VACCINE;

ADAPTIVE IMMUNITY; ARTICLE; CELLULAR IMMUNITY; DISEASE ASSOCIATION; HUMAN; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; NONHUMAN; OBESITY; RISK FACTOR; VIRUS VIRULENCE; ADULT; ANIMAL; CHILD; COMPLICATION; DISEASE MODEL; IMMUNOLOGY; MOUSE; ORTHOMYXOVIRUS INFECTION; PATHOPHYSIOLOGY;

ADAPTIVE IMMUNITY; ADULT; ANIMALS; CHILD; DISEASE MODELS, ANIMAL; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MICE; OBESITY; ORTHOMYXOVIRIDAE INFECTIONS; RISK FACTORS;

EID: 85035123089     PISSN: 23256621     EISSN: None     Source Type: Journal    
DOI: 10.1513/AnnalsATS.201706-447AW     Document Type: Article

References (34)

1. Rolfes MA, Foppa IM, Garg S, Flannery B, Brammer L, Singleton JA, Burns E, Jernigan D, Reed C, Olsen SJ, et al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. Atlanta, GA: Centers for Disease Control and Prevention [updated 2017 Apr 19; accessed 2017 Jul 18]. Available from: https://www.cdc.gov/flu/about/disease/2015-16. htm
2. World Health Organization (WHO). Influenza (seasonal): fact sheet. Geneva, Switzerland: WHO [updated 2016 Nov; accessed 2017 Jul 18]. Available from: http://www.who.int/mediacentre/factsheets/ fs211/en/
3. Lowen AC, Mubareka S, Steel J, Palese P. Influenza virus transmission is dependent on relative humidity and temperature. PLoS Pathog 2007;3:1470-1476.
4. Chiu C, Ellebedy AH, Wrammert J, Ahmed R. B cell responses to influenza infection and vaccination. In: Oldstone MBA, Compans RW, editors. Influenza pathogenesis and control. Vol. II. New York: Springer; 2015. pp. 381-398.
5. Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection. Virus Res 2011;162:19-30.
6. Watanabe T, Kawaoka Y. Pathogenesis of the 1918 pandemic influenza virus. PLoS Pathog 2011;7:e1001218.
7. Lambert LC, Fauci AS. Influenza vaccines for the future. N Engl J Med 2010;363:2036-2044.
8. Whitley RJ, Monto AS. Prevention and treatment of influenza in highrisk groups: children, pregnant women, immunocompromised hosts, and nursing home residents. J Infect Dis 2006;194(Suppl 2): S133-S138.
9. Madan RP, Tan M, Fernandez-Sesma A,Moran TM, Emre S, Campbell A, Herold BC. A prospective, comparative study of the immune response to inactivated influenza vaccine in pediatric liver transplant recipients and their healthy siblings. Clin Infect Dis 2008;46:712-718.
10. He XS, Holmes TH, Zhang C, Mahmood K, Kemble GW, Lewis DB, Dekker CL, Greenberg HB, Arvin AM. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol 2006;80:11756-11766.
11. Huttunen R, Syrjänen J. Obesity and the outcome of infection. Lancet Infect Dis 2010;10:442-443.
12. Milner JJ, Beck MA. The impact of obesity on the immune response to infection. Proc Nutr Soc 2012;71:298-306.
13. Louie JK, Acosta M, Samuel MC, Schechter R, Vugia DJ, Harriman K, Matyas BT; California Pandemic (H1N1) Working Group. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011;52:301-312.
14. Kwong JC, Campitelli MA, Rosella LC. Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study. Clin Infect Dis 2011;53:413-421.
15. NCD Risk Factor Collaboration (NCD-RisC). Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.$2 million participants. Lancet 2016;387:1377-1396.
16. Huttunen R, Syrjänen J. Obesity and the risk and outcome of infection. Int J Obes 2013;37:333-340.
17. Nilsson C, Raun K, Yan FF, Larsen MO, Tang-Christensen M. Laboratory animals as surrogate models of human obesity. Acta Pharmacol Sin 2012;33:173-181.
18. Milner JJ, Rebeles J, Dhungana S, Stewart DA, Sumner SC, Meyers MH, Mancuso P, Beck MA. Obesity increases mortality and modulates the lung metabolome during pandemic H1N1 influenza virus infection in mice. J Immunol 2015;194:4846-4859.
19. Milner JJ, Sheridan PA, Karlsson EA, Schultz-Cherry S, Shi Q, Beck MA. Diet-induced obese mice exhibit altered heterologous immunity during a secondary 2009 pandemic H1N1 infection. J Immunol 2013; 191:2474-2485.
20. Karlsson EA, Sheridan PA, Beck MA. Diet-induced obesity in mice reduces the maintenance of influenza-specific CD81 memory T cells. J Nutr 2010;140:1691-1697.
21. Kosaraju R, GuesdonW, Crouch MJ, Teague HL, Sullivan EM, Karlsson EA, Schultz-Cherry S, Gowdy K, Bridges LC, Reese LR, et al. B cell activity is impaired in human and mouse obesity and is responsive to an essential fatty acid upon murine influenza infection. J Immunol 2017;198: 4738-4752.
22. Karlsson EA, Hertz T, Johnson C, Mehle A, Krammer F, Schultz-Cherry S. Obesity outweighs protection conferred by adjuvanted influenza vaccination. MBio 2016;7:e01144-16.
23. Radigan KA, Morales-Nebreda L, Soberanes S, Nicholson T, Nigdelioglu R, Cho T, Chi M, Hamanaka RB, Misharin AV, Perlman H, et al. Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages. PLoS One 2014;9:e108138.
24. Saucillo DC, Gerriets VA, Sheng J, Rathmell JC, MacIver NJ. Leptin metabolically licenses T cells for activation to link nutrition and immunity. J Immunol 2014;192:136-144.
25. Milner JJ, Wang J, Sheridan PA, Ebbels T, Beck MA, Saric J. 1H NMRbased profiling reveals differential immune-metabolic networks during influenza virus infection in obese mice. PLoS One 2014;9: e97238.
26. Sheridan PA, Paich HA, Handy J, Karlsson EA, HudgensMG, Sammon AB, Holland LA, Weir S, Noah TL, Beck MA. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes 2012;36:1072-1077.
27. Paich HA, Sheridan PA, Handy J, Karlsson EA, Schultz-Cherry S, Hudgens MG, Noah TL, Weir SS, Beck MA. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus. Obesity (Silver Spring) 2013;21: 2377-2386.
28. Neidich SD, Green WD, Rebeles J, Karlsson EA, Schultz-Cherry S, Noah TL, Chakladar S, Hudgens MG, Weir SS, Beck MA. Increased risk of influenza among vaccinated adults who are obese. Int J Obes (Lond) 2017;41:1324-1330.
29. MacIver NJ, Michalek RD, Rathmell JC. Metabolic regulation of T lymphocytes. Annu Rev Immunol 2013;31:259-283.
30. Buck MD, O'Sullivan D, Pearce EL. T cell metabolism drives immunity. J Exp Med 2015;212:1345-1360.
31. Fischer HJ, Sie C, Schumann E, Witte AK, Dressel R, van den Brandt J, Reichardt HM. The insulin receptor plays a critical role in T cell function and adaptive immunity. J Immunol 2017;198:1910-1920.
32. Green WD, Beck MA. Obesity altered T cell metabolism and the response to infection. Curr Opin Immunol 2017;46:1-7.
33. Xiao L, Yang X, Lin Y, Li S, Jiang J, Qian S, Tang Q, He R, Li X. Large adipocytes function as antigen-presenting cells to activate CD41 T cells via upregulating MHCII in obesity. Int J Obes 2016;40:112-120.
34. Park HL, Shim SH, Lee EY, Cho W, Park S, Jeon HJ, Ahn SY, Kim H, Nam JH. Obesity-induced chronic inflammation is associated with the reduced efficacy of influenza vaccine. Hum Vaccin Immunother 2014;10:1181-1186.